IORDANIS VAGIAKIS

Mr. IORDANIS VAGIAKIS

1ST DEPARTMENT OF OPHTHALMOLOGY, AHEPA University Hospital, Thessaloníki, Kentrikí Makedonía, Greece
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
IVIORDANIS VAGIAKIS
IORDANIS VAGIAKIS
EPEleni P Papadopoulou
Eleni P Papadopoulou
EAEfstratia Amaxilati
Efstratia Amaxilati
GTGeorgios N Tsiropoulos
Georgios N Tsiropoulos
AKAnastasios G Konstas
Anastasios G Konstas
Georgios D. PanosGeorgios D. Panos
Georgios D. Panos
The bimatoprost intracameral implant (Durysta®) offers a sustained-release approach to glaucoma management, providing consistent intraocular pressure (IOP) reduction over several months and reducing the need for daily topical therapies. This review evaluates its pharmacology, efficacy, and safety, using data from pivotal clinical trials and recent real-world studies. The implant achieves IOP reductions comparable to topical prostaglandin analogs, with benefits for patient adherence and fewer common side effects. However, repeat administrations are associated with adverse effects such as endothelial cell loss, highlighting the need for optimized re-dosing schedules. Future research should explore its use in advanced glaucomas, cost-effectiveness, and combination with other IOP-lowering treatments. The bimatoprost intracameral implant represents a promising innovation in glaucoma therapy with potential for improved patient outcomes.

11 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KBKonstantinos Benekos
Konstantinos Benekos
AKAndreas Katsanos
Andreas Katsanos
PLPanagiotis Laspas
Panagiotis Laspas
IVIORDANIS VAGIAKIS
IORDANIS VAGIAKIS
AHAnna-Bettina Haidich
Anna-Bettina Haidich
AKAnastasios G. Konstas
Anastasios G. Konstas
Objectives: The objective of this systematic review and meta-analysis is to evaluate the existing evidence and estimate the impact of phacoemulsification and intraocular lens implantation on the intraocular pressure (IOP) of subjects with exfoliation syndrome (XFS) or exfoliative glaucoma (XFG). Methods: In July 2024, an in-depth literature review across three databases was undertaken. This study focused only on adult patients with exfoliation who had not undergone previous ocular surgery. The primary outcome of interest was the mean IOP reduction at 6 and 12 months after uncomplicated phacoemulsification surgery. Results: This meta-analysis included one randomized controlled trial and eight observational studies, comprising 220 patients at 6 months and 430 patients at the 12-month time point, respectively. The mean IOP reduction after surgery was 3.43 mmHg (95% CI: −4.77 to −2.09) after 6 months and 2.75 mmHg (95% CI: −4.24 to −1.26) after 12 months. In both time points, there was no heterogeneity (I2 = 0), but the certainty of evidence following the GRADE evaluation was very low. Conclusions: The present meta-analysis demonstrates that phacoemulsification can significantly reduce IOP in exfoliation subjects 6 and 12 months after surgery. Nevertheless, significant limitations in included studies do not allow a precise and certain estimate of the magnitude of postoperative IOP lowering in exfoliation patients. Additional research is needed to confirm these results.

9 August 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
IVIORDANIS VAGIAKIS
IORDANIS VAGIAKIS
Christos BakirtzisChristos Bakirtzis
Christos Bakirtzis
AAAthina Andravizou
Athina Andravizou
DPDemetrios Pirounides
Demetrios Pirounides
Alzheimer’s disease is the most prevalent form of dementia. Apart from its traditional clinical diagnostic methods, novel ocular imaging biomarkers have the potential to significantly enhance the diagnosis of Alzheimer’s disease. Ophthalmologists might be able to play a crucial role in this multidisciplinary approach, aiding in the early detection and diagnosis of Alzheimer’s disease through the use of advanced retinal imaging techniques. This systematic literature review the utilization of optical coherence tomography angiography biomarkers, specifically vessel density and the foveal avascular zone, for the diagnosis of Alzheimer’s disease. A comprehensive search was performed across multiple academic journal databases, including 11 relevant studies. The selected studies underwent thorough analysis to assess the potential of these optical coherence tomography angiography biomarkers as diagnostic tools for Alzheimer’s disease. The assessment of vessel density and the foveal avascular zone have emerged as a promising avenue for identifying and diagnosing Alzheimer’s disease. However, it is imperative to acknowledge that further targeted investigations are warranted to address the inherent limitations of the existing body of literature. These limitations encompass various factors such as modest sample sizes, heterogeneity among study populations, disparities in optical coherence tomography angiography imaging protocols, and inconsistencies in the reported findings. In order to establish the clinical utility and robustness of these biomarkers in Alzheimer’s disease diagnosis, future research endeavors should strive to overcome these limitations by implementing larger-scale studies characterized by standardized protocols and comprehensive assessments.


27 July 2026 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
RBRodanthi Christina Bartzoulianou
Rodanthi Christina Bartzoulianou
ACAnne L. Coleman
Anne L. Coleman
MWM. Roy Wilson
M. Roy Wilson
AHAlon Harris
Alon Harris
DGDimitrios A. Giannoulis
Dimitrios A. Giannoulis
FTFotis Topouzis
Fotis Topouzis

19 October 2024 in Vision
Verified
Journal Article
Open access
PDF file
NDNikolaos Dervenis
Nikolaos Dervenis
IVIORDANIS VAGIAKIS
IORDANIS VAGIAKIS
EPEleni Papadopoulou
Eleni Papadopoulou
PDPanagiotis Dervenis
Panagiotis Dervenis
MSMaria Teresa Sandinha
Maria Teresa Sandinha
We are presenting a new method for the treatment of large macular holes (MHs) with the use of an inverted flap consisting of both internal limiting membrane (ILM) and epiretinal proliferation (EP). A prospective interventional case series was conducted from September 2021 to January 2023. MH patients with coexistent EP visualized preoperatively in macula optical coherence tomography and with a MHs minimum linear diameter larger than 400 microns underwent standard pars plana vitrectomy with the creation of an inverted petaloid flap (consisting of both ILM and EP) and gas tamponade. Sixteen eyes were included in our case series. MHs closure was successful in all the eyes with a single procedure. The preoperative minimum linear diameter was 707.63 (±164.02 μm), and the preoperative best corrected visual acuity was 1.11 ± 0.52. The postoperative BCVA was 0.51 ± 0.20 (p = 0.01) at 6 weeks postoperatively, and the final BCVA was 0.45 ± 0.20 (p = 0.008). EP can be safely combined with ILM for the creation of an inverted, petaloid flap to cover and facilitate the closure of large MHs.